Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response

被引:648
|
作者
Astuti, Indwiani [1 ]
Ysrafil [1 ]
机构
[1] Univ Gadjah Mada, Dept Pharmacol & Therapy, Fac Med Publ Hlth & Nurses, Yogyakarta 55281, Indonesia
关键词
COVID-19; SARS-CoV-2; Pandemic; ACE2; Wuhan; RECEPTOR-BINDING DOMAIN; SPIKE PROTEIN; IMMUNE-RESPONSES; SARS-COV; NEUTRALIZING ANTIBODIES; COVID-19; VACCINE; INFECTION; ENZYMES; TARGET;
D O I
10.1016/j.dsx.2020.04.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim: As a result of its rapid spread in various countries around the world, on March 11, 2020, WHO issued an announcement of the change in coronavirus disease 2019 status from epidemic to pandemic disease. The virus that causes this disease is indicated originating from animals traded in a live animal market in Wuhan, China. Severe Acute Respiratory Syndrome Coronavirus 2 can attack lung cells because there are many conserved receptor entries, namely Angiotensin Converting Enzyme-2. The presence of this virus in host cells will initiate various protective responses leading to pneumonia and Acute Respiratory Distress Syndrome. This review aimed to provide an overview related to this virus and examine the body's responses and possible therapies. Method: We searched PubMed databases for Severe Acute Respiratory Syndrome Coronavirus-2, Middle East respiratory syndrome-related coronavirus and Severe Acute Respiratory Syndrome Coronavirus. Full texts were retrieved, analyzed and developed into an easy-to-understand review. Results: We provide a complete review related to structure, origin, and how the body responds to this virus infection and explain the possibility of an immune system over-reaction or cytokine storm. We also include an explanation of how this virus creates modes of avoidance to evade immune system attacks. We further explain the therapeutic approaches that can be taken in the treatment and prevention of this viral infection. Conclusion: In summary, based on the structural and immune-evasion system of coronavirus, we suggest several approaches to treat the disease. (C) 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 50 条
  • [31] The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion?
    Wang, Zhihui
    Zhou, Ming
    Fu, Zhenfang
    Zhao, Ling
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [32] Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Emerging Zoonotic Respiratory Pathogen in Humans
    Malla, Ashwini
    Shanmugaraj, Balamurugan
    Ramalingam, Sathishkumar
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2020, 14 : 931 - 936
  • [33] Therapeutic Targets in the Virological Mechanism and in the Hyperinflammatory Response of Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)
    Astasio-Picado, Alvaro
    Zabala-Banos, Maria del Carmen
    Jurado-Palomo, Jesus
    APPLIED SCIENCES-BASEL, 2023, 13 (07):
  • [34] Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry
    Wandernoth, Petra
    Kriegsmann, Katharina
    Groh-Mohanu, Cristina
    Daeumer, Martin
    Gohl, Peter
    Harzer, Oliver
    Kriegsmann, Mark
    Kriegsmann, Joerg
    VIRUSES-BASEL, 2020, 12 (08):
  • [35] The landscape of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic mutations
    Lippi, Giuseppe
    Henry, Brandon M.
    JOURNAL OF LABORATORY AND PRECISION MEDICINE, 2022, 7
  • [36] Smoking and the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
    Lee, Sang Chul
    Son, Kang Ju
    Kim, Dong Wook
    Han, Chang Hoon
    Choi, Yoon Jung
    Kim, Seong Woo
    Park, Seon Cheol
    NICOTINE & TOBACCO RESEARCH, 2021, 23 (10) : 1787 - 1792
  • [37] The landscape of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic mutations
    Lippi, Giuseppe
    Henry, Brandon M.
    JOURNAL OF LABORATORY AND PRECISION MEDICINE, 2022, 7
  • [38] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) coinfection: A unique case series
    Elhazmi, Alyaa
    Al-Tawfiq, Jaffar A.
    Sallam, Hend
    Al-Omari, Awad
    Alhumaid, Saad
    Mady, Ahmad
    Al Mutair, Abbas
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2021, 41
  • [39] Dismantling myths on the airborne transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
    Tang, J. W.
    Bahnfleth, W. P.
    Bluyssen, P. M.
    Buonanno, G.
    Jimenez, J. L.
    Kurnitski, J.
    Li, Y.
    Miller, S.
    Sekhar, C.
    Morawska, L.
    Marr, L. C.
    Melikov, A. K.
    Nazaroff, W. W.
    Nielsen, P., V
    Tellier, R.
    Wargocki, P.
    Dancer, S. J.
    JOURNAL OF HOSPITAL INFECTION, 2021, 110 : 89 - 96
  • [40] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its effect on gametogenesis and early pregnancy
    Singh, Bhuchitra
    Gornet, Megan
    Sims, Holly
    Kisanga, Edwina
    Knight, Zachary
    Segars, James
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2020, 84 (05)